ADVERSE EVENTS ASSOCIATED WITH mTOR INHIBITION: RESULTS FROM THE A2310 STUDY COMPARING EVEROLIMUS AND MMF IN DE NOVO HEART TRANSPLANT RECIPIENTS

被引：0
|
作者：
Poncelet, A. [1 ]
Musumeci, F. [2 ]
Fuchs, U. [3 ]
Mattei, M. F. [4 ]
Dong, G. [5 ]
Lopez, P. [6 ]
Hirt, S. [7 ]
机构：
[1] Catholic Univ Louvain, Fac Med, B-1200 Brussels, Belgium
[2] S Camillo Forlanini Hosp, Dept Cardiovasc Sci, Rome, Italy
[3] Ruhr Univ Bochum, Heart Ctr N Rhine Westphalia, Univ Hosp, Bad Oeynhausen, Germany
[4] Hop Brabois, Dept Cardiol & Transplantat, Nancy, France
[5] Novartis Pharmaceut, Dev, E Hanover, NJ USA
[6] Novartis Pharma AG, Clin Dev, Basel, Switzerland
[7] Univ Med Ctr Regensburg, Dept Cardiothorac Surg, Regensburg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [1] Adverse Events (AEs) Associated with Everolimus (EVR) or Mycophenolate Mofetil (MMF) in De Novo Heart Transplant (HTx) Recipients: Results from the North American (NA) Subpopulation of Study A2310
    Eisen, H.
    Ross, H.
    Pauly, D.
    Kfoury, A.
    Van Bakel, A.
    Starling, R.
    Patel, D.
    Wiland, A.
    Lopez, P.
    Balfour, A.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S200 - S201
  • [2] Cardiovascular Events with De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study
    Potena, L.
    Schultz, U.
    Bara, C.
    Arizon, J. M.
    Dong, G.
    Lopez, P.
    Epailly, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S26 - S26
  • [3] Safety Events of Interest with the De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study
    Lehmkuhl, H.
    Hirt, S.
    Rinaldi, M.
    Bara, C.
    Zuckermann, A.
    Lopez, P.
    Cines, M.
    Dong, G.
    Keogh, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 74 - 75
  • [4] Efficacy and Renal Function in De NOVO Heart Transplant Recipients Receiving Everolimus with Reduced CsA Compared to MMF with Standard CsA: The A2310 Study
    Eisen, H. J.
    Pauly, D.
    Starling, R.
    Kfoury, A.
    Ross, H.
    Wang, S.
    Cantin, B.
    Hirt, S.
    Lehmkuhl, H.
    Ewald, G.
    Van Bakel, A.
    Zuckermann, A.
    Lopez, P.
    Dong, G.
    Pains, C.
    Jiang, H.
    Cornu-Artis, C.
    Kobashigawa, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 129 - 130
  • [5] EFFICACY AND RENAL FUNCTION IN DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS WITH REDUCED CSA COMPARED TO MMF WITH STANDARD CSA: THE A2310 STUDY
    Bara, C.
    Eisen, H.
    Hirt, S.
    Costard-Jaeckle, A.
    Schulz, U.
    Lopez, P.
    Kobashigawa, J.
    Lehmkuhl, H. B.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 22 - 22
  • [6] Effect of Everolimus Based Immunosuppression on De Novo Heart Transplant Recipients-24 Months Efficacy and Safety Results from A2310 Study
    Kobashigawa, J.
    Pauly, D.
    Kfoury, A.
    Ross, H.
    Wang, S. -S.
    Cantin, B.
    van Bakel, A.
    Starling, R.
    Hirt, S.
    Dong, G.
    Panis, C.
    Lopez, P.
    Eisen, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 67 - 68
  • [7] DE NOVO USE OF EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS: CORRELATION BETWEEN LIPID LEVELS AND CARDIOVASCULAR EVENTS BASED ON THE 24 MONTH RESULTS OF A2310 STUDY
    Potena, Luciano
    Bara, Christoph
    Dong, Gaohong
    Lopez, Patricia
    Epailly, Eric
    TRANSPLANT INTERNATIONAL, 2015, 28 : 436 - 436
  • [8] mTOR Inhibitor Attributed Adverse Events: Results from the H2304 Study Comparing Everolimus and Tacrolimus in De Novo Liver Transplant Recipients
    Fischer, L.
    De Simone, P.
    Fung, J.
    Nevens, F.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Chavin, K.
    Chapman, W. C.
    Jiang, H.
    Lopez, P.
    Junge, G.
    De Carlis, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 126 - 126
  • [9] 24-Month Safety and Efficacy of Concentration Controlled Everolimus with Reduced Cyclosporine Versus Mycophenolate Mofetil in 721 De Novo Heart Transplant Recipients: Results from the A2310 Study
    Epailly, E.
    Eisen, H.
    Pauly, D.
    Hirt, S.
    Lehmkuhl, H.
    Andreassen, A.
    Rinaldi, M.
    Yonan, N.
    Potena, L.
    Zuckermann, A.
    Dong, G.
    Panis, C.
    Lopez, P.
    Kobashigawa, J.
    TRANSPLANTATION, 2012, 94 (10) : 127 - 127
  • [10] RANDOMIZED, COMPARATIVE, MULTICENTER STUDY RAD2310 COMPARING EVEROLIMUS AND MMF IN DE NOVO HEART TRANSPLANTATION: RESULTS AT 2 YEARS
    Boisssonnat, Pascale
    Epailly, Eric
    Sebbag, Laurent
    Mattei, Sophie
    Guillemain, Romain
    Varnous, Shaida
    Gandjbakhch, Iradj
    TRANSPLANT INTERNATIONAL, 2012, 25 : 25 - 25
12345